Effects of Chinese herbs on salivary fluid secretion by isolated and perfused rat submandibular glan

来源 :世界胃肠病学杂志(英文版) | 被引量 : 0次 | 上传用户:xingke198621
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
AIM: To determine whether Chinese herbs (CHs) relieve xerostomia (dry mouth) by increasing salivary secretion.METHODS: The submandibular glands of Wistar rats were surgically isolated and perfused arterially with buffered salt solution. After control perfusion,recording started 5 min prior to the start of stimulation.After fluid secretion was induced by 0.2 mmol/L carbamylcholine (CCh) in the perfusate for 10 min,Chinese herb (CH) was added in the perfusion for 5 min. CCh was then overloaded at 0.2 mmol/L in the perfusion for 20 min. The volume of salivary fluid secretion was recorded by a computer-controlled balance system.RESULTS: Saliva secretion formed an initial ephemeral peak at 30 s followed by a gradual increase to a sustained level. CH alone induced no or little saliva in all types of CH selected. During perfusion with CH ,overloading of CCh promoted fluid secretion in 15 of 20 CHs. This promotion was classified into four patts,which were eventually related to the categories of CH: Overall sustained phase was continuously raised ( Yin-nourishing, fluid production-promoting and heatclearing agents); The sustained secretion rose to reach a maximum then decreased ( Qi-enhancing agent); Sustained secretion rose to reach the highest maximum and was then sustained with a slight decline (swelling-reducing, phlegm-resolving and pus-expelling agents); Stimulation of salivary secretion without any added stimulants. Addition of CCh raised the fluid secretion to reach the highest maximum then sharply decreased to a lower sustained level (blood activating agent).CONCLUSION: The present findings lead to the conclusion that various CHs have different promotional effects directly on the salivary gland.
其他文献
尿液排出体外前一直存储在膀胱中.因此监测尿糖时,其实测定的是膀胱中尿液糖的平均浓度,它所反映的是一段时间内血糖的平均水平,而不是监测当时的血糖水平.从这一点上讲,它和
期刊
引言高血压现在被认为是糖尿病人群发生大血管和微血管并发症的一个主要危险因素,与过早死亡和死亡率增加有着很大关联。然而,搞清楚我们认识到血压是糖尿病患者一个重要危险
肝内胆管癌(ICC)是发病率仅次于肝细胞癌的原发性肝癌,近20年来ICC的发病率在全世界范围内显著增高。肝切除术是该病目前唯一可能获得远期生存的有效治疗方式,但可切除肿瘤的比例较低,仅少部分患者可能获得根治性切除机会。ICC具有很强的侵袭性,其病灶常呈多灶性及肝内浸润,伴极高的淋巴结转移及血管侵犯概率,因此,患者肝切除术后的长期生存率不理想。肝移植在ICC中的治疗价值仍有争议,其他局部和全身化疗对
期刊
一般显著的血糖增高,尿糖会呈阳性,化验尿就出现“+”号.血糖越高,尿糖的“+”号也越多,可以达到4个“+”号.因此检查尿糖,发现“+”,可以提供一个血糖可能升高的线索.实际上
期刊
确定及描述糖尿病致病或易感基因是生物医学研究的焦点之一.目前,对胰腺β细胞功能缺陷所致糖尿病背后的单基因遗传分子机制研究较多,但是,要想发现导致2型糖尿病(T2DM)遗传
1一般资料患者,女性,78岁,因高血压入院。主诉:左侧手指瘙痒、麻木20余天,末端颜色略青紫,皮肤温度低于正常,疼痛2 d。查体:⑴体温正常;⑵左侧上肢血压未测出;⑶左侧手指屈伸
胆道肿瘤是一种预后极差的疾病。目前,仅有小部分的早期患者可以接受根治性切除术,而传统放疗、化疗、靶向治疗等对胆道肿瘤作用有限。免疫系统在胆道肿瘤的发病机理中扮演重要角色。因此,以程序性细胞死亡蛋白-1及其配体(PD-1/PD-L1)抑制剂为代表的免疫检查点抑制剂在胆道肿瘤的治疗中具有巨大潜在价值。笔者分析国内外最新研究进展,结合自身治疗经验与当前临床热点问题,深入探讨PD-1/PD-L1抑制剂在胆
期刊